Thrivent Financial for Lutherans Acquires New Stake in National Health Investors, Inc. (NYSE:NHI)

Thrivent Financial for Lutherans bought a new stake in National Health Investors, Inc. (NYSE:NHI) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 28,858 shares of the real estate investment trust’s stock, valued at approximately $2,426,000. Thrivent Financial for Lutherans owned 0.07% of National Health Investors as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Metis Global Partners LLC increased its position in National Health Investors by 31.2% during the 3rd quarter. Metis Global Partners LLC now owns 4,474 shares of the real estate investment trust’s stock worth $376,000 after purchasing an additional 1,065 shares in the last quarter. Pinnacle Financial Partners Inc lifted its position in National Health Investors by 7.7% during the 3rd quarter. Pinnacle Financial Partners Inc now owns 49,488 shares of the real estate investment trust’s stock worth $4,160,000 after acquiring an additional 3,546 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of National Health Investors by 3.1% in the 3rd quarter. Victory Capital Management Inc. now owns 24,405 shares of the real estate investment trust’s stock valued at $2,051,000 after purchasing an additional 739 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd acquired a new position in shares of National Health Investors in the 3rd quarter valued at approximately $2,017,000. Finally, Covestor Ltd raised its position in shares of National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 405 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Stock Performance

NHI opened at $76.91 on Thursday. The firm has a market capitalization of $3.49 billion, a P/E ratio of 26.66, a price-to-earnings-growth ratio of 5.14 and a beta of 1.05. The stock’s 50 day moving average price is $79.17 and its two-hundred day moving average price is $74.66. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The firm had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. During the same period in the previous year, the business posted $1.08 EPS. National Health Investors’s revenue for the quarter was up 1.7% compared to the same quarter last year. On average, equities analysts forecast that National Health Investors, Inc. will post 4.42 earnings per share for the current year.

National Health Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.68%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is 123.71%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and upped their price objective for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Bank of America began coverage on National Health Investors in a report on Tuesday, September 24th. They set a “buy” rating and a $92.00 target price for the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Finally, Truist Financial upped their target price on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $73.29.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.